eli lilly glp 1 drug Novo, weight-loss drugs should be first option obesity treatments, European doctors say Shortages improve for Lilly's GLP-1

If medication side effects prevent you from reaching your nutrition goals, the dosage may need to be adjusted. Supplementation with whey protein and essential amino acids can also help meet the desired daily protein intake and facilitate muscle protein synthesis

Unlike semaglutide, which targets GLP-1 only, or tirzepatide (GLP-1 + GIP), Retatrutide adds glucagon receptor activity that increases resting energy expenditure, a mechanism not present in either predecessor

Its principal application is in the study of metabolic syndrome and its hepatic manifestation, non-alcoholic fatty liver disease (NAFLD)

Limitations of the study The study enrolled patients with active RA, with a significant proportion receiving dual or triple DMARDs therapy